A detailed history of Osterweis Capital Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Osterweis Capital Management Inc holds 11,245 shares of LLY stock, worth $8.95 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
11,245
Previous 11,485 2.09%
Holding current value
$8.95 Million
Previous $10.4 Million 4.19%
% of portfolio
0.6%
Previous 0.67%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $185,313 - $230,404
-240 Reduced 2.09%
11,245 $9.96 Million
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $516,832 - $648,145
-713 Reduced 5.85%
11,485 $10.4 Million
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $532,980 - $713,052
-900 Reduced 6.87%
12,198 $9.49 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $307,761 - $362,810
-586 Reduced 4.28%
13,098 $7.64 Million
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $227,981 - $304,837
-650 Reduced 4.53%
13,684 $6.42 Million
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $85,733 - $100,690
-276 Reduced 1.89%
14,334 $4.92 Million
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $18,006 - $20,981
-56 Reduced 0.38%
14,610 $5.34 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $281,656 - $320,976
-950 Reduced 6.08%
14,666 $4.74 Million
Q2 2021

Aug 16, 2021

SELL
$180.55 - $233.54 $12,819 - $16,581
-71 Reduced 0.45%
15,616 $3.58 Million
Q4 2020

Feb 12, 2021

SELL
$130.46 - $172.63 $1.07 Million - $1.41 Million
-8,188 Reduced 34.3%
15,687 $2.65 Million
Q4 2019

Feb 14, 2020

SELL
$106.92 - $132.43 $5,880 - $7,283
-55 Reduced 0.23%
23,875 $3.14 Million
Q3 2019

Nov 14, 2019

BUY
$106.79 - $116.16 $31,075 - $33,802
291 Added 1.23%
23,930 $2.68 Million
Q4 2018

Feb 14, 2019

SELL
$105.9 - $118.64 $105,900 - $118,640
-1,000 Reduced 4.06%
23,639 $2.74 Million
Q3 2017

Nov 13, 2017

BUY
$77.07 - $85.54 $1.9 Million - $2.11 Million
24,639
24,639 $2.11 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Osterweis Capital Management Inc Portfolio

Follow Osterweis Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Osterweis Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Osterweis Capital Management Inc with notifications on news.